<DOC>
	<DOCNO>NCT02228811</DOCNO>
	<brief_summary>The main purpose study investigate safety investigational drug DCC-2701 whether work help people advance solid tumor cancer spread part body .</brief_summary>
	<brief_title>A Study DCC-2701 Participants With Advanced Solid Tumors</brief_title>
	<detailed_description>This first-in-human study DCC-2701 . The primary purpose study determine dose DCC-2701 , give safely patient advance solid tumor . The study two phase . The first phase ass escalate dos DCC-2701 order determine maximally tolerate dose ( MTD ) optimal dose regimen ( ODR ) DCC-2701 . Once MTD ODR establish , dose expansion phase evaluate safety DCC-2701 , well activity DCC-2701 select solid tumor type .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<criteria>Advanced metastatic solid tumor progress responsive standard therapy The cancer proven effective therapy The cancer biopsied ( depend tumor type and/or dose drug receive , tumor biopsy may require ) Able swallow tablet Have active central nervous system ( CNS ) metastasis Have active infection kind ( fungal , viral , bacterial ) Are pregnant breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>